vs

Side-by-side financial comparison of James River Group Holdings, Inc. (JRVR) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.

UNIVERSAL TECHNICAL INSTITUTE INC is the larger business by last-quarter revenue ($220.8M vs $167.7M, roughly 1.3× James River Group Holdings, Inc.). James River Group Holdings, Inc. runs the higher net margin — 19.1% vs 5.8%, a 13.3% gap on every dollar of revenue. On growth, James River Group Holdings, Inc. posted the faster year-over-year revenue change (32.4% vs 9.6%). UNIVERSAL TECHNICAL INSTITUTE INC produced more free cash flow last quarter ($-19.2M vs $-23.6M). Over the past eight quarters, UNIVERSAL TECHNICAL INSTITUTE INC's revenue compounded faster (9.5% CAGR vs -8.7%).

James River Corporation was an American pulp and paper company based in Richmond, Virginia, once the largest paper manufacturer in the world.

Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.

JRVR vs UTI — Head-to-Head

Bigger by revenue
UTI
UTI
1.3× larger
UTI
$220.8M
$167.7M
JRVR
Growing faster (revenue YoY)
JRVR
JRVR
+22.7% gap
JRVR
32.4%
9.6%
UTI
Higher net margin
JRVR
JRVR
13.3% more per $
JRVR
19.1%
5.8%
UTI
More free cash flow
UTI
UTI
$4.4M more FCF
UTI
$-19.2M
$-23.6M
JRVR
Faster 2-yr revenue CAGR
UTI
UTI
Annualised
UTI
9.5%
-8.7%
JRVR

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
JRVR
JRVR
UTI
UTI
Revenue
$167.7M
$220.8M
Net Profit
$32.1M
$12.8M
Gross Margin
Operating Margin
14.6%
7.1%
Net Margin
19.1%
5.8%
Revenue YoY
32.4%
9.6%
Net Profit YoY
149.5%
-42.1%
EPS (diluted)
$0.59
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
JRVR
JRVR
UTI
UTI
Q4 25
$167.7M
$220.8M
Q3 25
$172.7M
$222.4M
Q2 25
$174.8M
$204.3M
Q1 25
$172.3M
$207.4M
Q4 24
$126.7M
$201.4M
Q3 24
$191.5M
$196.4M
Q2 24
$188.3M
$177.5M
Q1 24
$201.1M
$184.2M
Net Profit
JRVR
JRVR
UTI
UTI
Q4 25
$32.1M
$12.8M
Q3 25
$1.0M
$18.8M
Q2 25
$4.8M
$10.7M
Q1 25
$9.6M
$11.4M
Q4 24
$-64.8M
$22.2M
Q3 24
$-39.4M
$18.8M
Q2 24
$7.6M
$5.0M
Q1 24
$15.4M
$7.8M
Operating Margin
JRVR
JRVR
UTI
UTI
Q4 25
14.6%
7.1%
Q3 25
1.5%
11.2%
Q2 25
4.2%
6.9%
Q1 25
9.3%
8.1%
Q4 24
-57.0%
13.6%
Q3 24
-27.1%
13.3%
Q2 24
10.7%
4.2%
Q1 24
16.4%
6.1%
Net Margin
JRVR
JRVR
UTI
UTI
Q4 25
19.1%
5.8%
Q3 25
0.6%
8.4%
Q2 25
2.7%
5.2%
Q1 25
5.6%
5.5%
Q4 24
-51.1%
11.0%
Q3 24
-20.6%
9.6%
Q2 24
4.0%
2.8%
Q1 24
7.7%
4.2%
EPS (diluted)
JRVR
JRVR
UTI
UTI
Q4 25
$0.59
$0.23
Q3 25
$-0.02
$0.33
Q2 25
$0.06
$0.19
Q1 25
$0.16
$0.21
Q4 24
$-2.44
$0.40
Q3 24
$-1.10
$0.35
Q2 24
$0.13
$0.09
Q1 24
$0.35
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
JRVR
JRVR
UTI
UTI
Cash + ST InvestmentsLiquidity on hand
$260.9M
$162.8M
Total DebtLower is stronger
$101.4M
Stockholders' EquityBook value
$538.2M
$335.9M
Total Assets
$4.9B
$834.0M
Debt / EquityLower = less leverage
0.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
JRVR
JRVR
UTI
UTI
Q4 25
$260.9M
$162.8M
Q3 25
$238.8M
$169.1M
Q2 25
$220.0M
$70.7M
Q1 25
$279.4M
$96.0M
Q4 24
$362.3M
$172.0M
Q3 24
$359.8M
$161.9M
Q2 24
$672.5M
$115.5M
Q1 24
$305.5M
$116.1M
Total Debt
JRVR
JRVR
UTI
UTI
Q4 25
$101.4M
Q3 25
$87.1M
Q2 25
$73.8M
Q1 25
$94.4M
Q4 24
$120.1M
Q3 24
$125.7M
Q2 24
$137.3M
Q1 24
$141.9M
Stockholders' Equity
JRVR
JRVR
UTI
UTI
Q4 25
$538.2M
$335.9M
Q3 25
$503.6M
$328.1M
Q2 25
$492.6M
$306.8M
Q1 25
$484.5M
$293.9M
Q4 24
$460.9M
$280.0M
Q3 24
$530.3M
$260.2M
Q2 24
$541.8M
$239.4M
Q1 24
$539.5M
$232.6M
Total Assets
JRVR
JRVR
UTI
UTI
Q4 25
$4.9B
$834.0M
Q3 25
$5.0B
$826.1M
Q2 25
$5.0B
$740.8M
Q1 25
$4.9B
$720.4M
Q4 24
$5.0B
$753.8M
Q3 24
$5.0B
$744.6M
Q2 24
$4.7B
$706.0M
Q1 24
$5.3B
$702.1M
Debt / Equity
JRVR
JRVR
UTI
UTI
Q4 25
0.30×
Q3 25
0.27×
Q2 25
0.24×
Q1 25
0.32×
Q4 24
0.43×
Q3 24
0.48×
Q2 24
0.57×
Q1 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
JRVR
JRVR
UTI
UTI
Operating Cash FlowLast quarter
$-18.8M
$3.1M
Free Cash FlowOCF − Capex
$-23.6M
$-19.2M
FCF MarginFCF / Revenue
-14.1%
-8.7%
Capex IntensityCapex / Revenue
2.9%
10.1%
Cash ConversionOCF / Net Profit
-0.59×
0.24×
TTM Free Cash FlowTrailing 4 quarters
$-17.9M
$16.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
JRVR
JRVR
UTI
UTI
Q4 25
$-18.8M
$3.1M
Q3 25
$34.3M
$57.1M
Q2 25
$25.2M
$18.1M
Q1 25
$-51.5M
$-789.0K
Q4 24
$-247.1M
$23.0M
Q3 24
$-269.9M
$67.5M
Q2 24
$-8.7M
$10.0M
Q1 24
$24.1M
$-2.5M
Free Cash Flow
JRVR
JRVR
UTI
UTI
Q4 25
$-23.6M
$-19.2M
Q3 25
$33.7M
$40.6M
Q2 25
$24.7M
$6.8M
Q1 25
$-52.7M
$-11.7M
Q4 24
$-252.0M
$19.6M
Q3 24
$-270.8M
$60.0M
Q2 24
$-9.3M
$3.0M
Q1 24
$23.3M
$-8.4M
FCF Margin
JRVR
JRVR
UTI
UTI
Q4 25
-14.1%
-8.7%
Q3 25
19.5%
18.3%
Q2 25
14.1%
3.4%
Q1 25
-30.6%
-5.7%
Q4 24
-198.9%
9.7%
Q3 24
-141.4%
30.6%
Q2 24
-4.9%
1.7%
Q1 24
11.6%
-4.6%
Capex Intensity
JRVR
JRVR
UTI
UTI
Q4 25
2.9%
10.1%
Q3 25
0.4%
7.4%
Q2 25
0.3%
5.5%
Q1 25
0.7%
5.3%
Q4 24
3.9%
1.7%
Q3 24
0.4%
3.8%
Q2 24
0.3%
4.0%
Q1 24
0.4%
3.2%
Cash Conversion
JRVR
JRVR
UTI
UTI
Q4 25
-0.59×
0.24×
Q3 25
33.61×
3.04×
Q2 25
5.29×
1.69×
Q1 25
-5.38×
-0.07×
Q4 24
1.04×
Q3 24
3.58×
Q2 24
-1.14×
2.01×
Q1 24
1.56×
-0.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

JRVR
JRVR

Excess And Surplus Lines$156.7M93%
Specialty Admitted Insurance$10.9M7%

UTI
UTI

UTI$142.8M65%
Concorde$78.0M35%

Related Comparisons